Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor “What This Means” Segment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor “What This Means” Segment
(NASDAQ: DARE) Delayed: 0.78 +0.03 (4.00%)
Previous Close $0.75    52 Week High $ 
Open $0.79    52 Week Low $ 
Day High $0.81    P/E N/A 
Day Low $0.77    EPS $ 
Volume 229,164       

(NASDAQ: DARE) Delayed: 0.78 +0.03 (4.00%)
Previous Close $0.75    52 Week High $ 
Open $0.79    52 Week Low $ 
Day High $0.81    P/E N/A 
Day Low $0.77    EPS $ 
Volume 229,164